Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of rhNRG-1 in chronic systolic heart failure
ChiCTR-TRC-09000415Phase 2Completed
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Jul 2007
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2 trial of neucardin in chronic heart failure (CHF) and heart failure with reduced ejection fraction (HFrEF) (3 arms), sponsored by Chinese Academy of Medical Sciences. Primary endpoint: 6-minute walk test distance. Started Jul 2007; status: completed.
02
Drugs
neucardin
03
Conditions
chronic heart failure (CHF)heart failure with reduced ejection fraction (HFrEF)
Beyond the preview
Go deeper on ChiCTR-TRC-09000415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-09000415.